| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |